Anna Partyka

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Molecular Dynamics Simulations

Protein Protein

Mild Cognitive Impairment

Top Venues

Molecules (Basel, Switzerland)

Neuropsychiatric disease and treatment

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Partyka, Katarzyna Górecka, Joanna Gdula- Argasińska, Natalia Wilczyńska-Zawal, Magdalena Jastrzębska-Więsek, Anna Wesołowska
Selective 5-HT 6 Receptor Ligands (Agonist and Antagonist) Show Different Effects on Antipsychotic Drug-Induced Metabolic Dysfunctions in Rats. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Przemysław Zaręba, Anna Partyka, Gniewomir Latacz, Grzegorz Satała, Paweł Zajdel, Jolanta Jaśkowska
New, Eco-Friendly Method for Synthesis of 3-Chlorophenyl and 1,1'-Biphenyl Piperazinylhexyl Trazodone Analogues with Dual 5-HT 1A /5-HT 7 Affinity and Its Antidepressant-like Activity. Molecules (Basel, Switzerland) 27 (21) (2022)
Anna Wesołowska, Joanna Rychtyk, Joanna Gdula-Argasińska, Katarzyna Górecka, Natalia Wilczyńska-Zawal, Magdalena Jastrzębska-Więsek, Anna Partyka
Effect of 5-HT6 Receptor Ligands Combined with Haloperidol or Risperidone on Antidepressant-/Anxiolytic-Like Behavior and BDNF Regulation in Hippocampus and Prefrontal Cortex of Rats. Neuropsychiatric disease and treatment 17 (2021)
Agnieszka Jankowska, Grzegorz Satała, Artur Świerczek, Krzysztof Pociecha, Anna Partyka, Magdalena Jastrzębska-Więsek, Monika Głuch-Lutwin, Andrzej J Bojarski, Elżbieta Wyska, Grażyna Chłoń-Rzepa
A new class of 5-HT1A receptor antagonists with procognitive and antidepressant properties. Future medicinal chemistry 13 (18) (2021)
Sylwia Sudoł, Agnieszka Cios, Magdalena Jastrzębska-Więsek, Ewelina Honkisz-Orzechowska, Barbara Mordyl, Natalia Wilczyńska-Zawal, Grzegorz Satała, Katarzyna Kucwaj-Brysz, Anna Partyka, Gniewomir Latacz, Agnieszka Olejarz-Maciej, Anna Wesołowska, Jadwiga Handzlik
The Phenoxyalkyltriazine Antagonists for 5-HT6 Receptor with Promising Procognitive and Pharmacokinetic Properties In Vivo in Search for a Novel Therapeutic Approach to Dementia Diseases. International journal of molecular sciences 22 (19) (2021)
Anna Czopek, Anna Partyka, Adam Bucki, Maciej Pawłowski, Marcin Kołaczkowski, Agata Siwek, Monika Głuch-Lutwin, Paulina Koczurkiewicz, Elżbieta Pękala, Anna Jaromin, Bozena Tyliszczak, Anna Wesołowska, Agnieszka Zagórska
Impact of N-Alkylamino Substituents on Serotonin Receptor (5-HTR) Affinity and Phosphodiesterase 10A (PDE10A) Inhibition of Isoindole-1,3-dione Derivatives. Molecules (Basel, Switzerland) 25 (17) (2020)
Anna Partyka, Agnieszka Zagórska, Magdalena Kotańska, Maria Walczak, Magdalena Jastrzębska-Więsek, Joanna Knutelska, Marek Bednarski, Monika Głuch-Lutwin, Barbara Mordyl, Paulina Janiszewska, Anna Wesołowska
Antidepressant-like activity and safety profile evaluation of 1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione derivatives as 5-HT1A receptor partial agonists. PloS one 15 (8) (2020)
Annamaria Lubelska, Gniewomir Latacz, Magdalena Jastrzębska-Więsek, Magdalena Kotańska, Rafał Kurczab, Anna Partyka, Małgorzata Anna Marć, Daria Wilczyńska, Agata Doroz-Płonka, Dorota Łażewska, Anna Wesołowska, Katarzyna Kieć-Kononowicz, Jadwiga Handzlik
Are the Hydantoin-1,3,5-triazine 5-HT6R Ligands a Hope to a Find New Procognitive and Anti-Obesity Drug? Considerations Based on Primary In Vivo Assays and ADME-Tox Profile In Vitro. Molecules (Basel, Switzerland) 24 (24) (2019)